Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 1030-1035

  Szalai, Alexander J ^a,d   Van Ginkel, Frederik W ^b   Wang, Yue ^a   McGhee, Jerry R ^b   Volanakis, John E ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID P COMPONENT; ANAPHYLATOXIN; C REACTIVE PROTEIN; COMPLEMENT; COMPLEMENT COMPONENT C5A; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TISSUE INJURY; TRANSGENIC MOUSE;

EID: 0034661981     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.1030     Document Type: Article

References (55)

1. Kushner, I. 1982. The phenomenon of the acute phase response, Ann. NY Acad. Sci. 389:39.
2. Gabay, S., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:448.
3. Kushner, I., and A. Mackiewicz. 1993. The acute phase response: an overview. In Acute Phase Proteins: Molecular Biology. Biochemistry, and Clinical Applications. A. Mackiewicz, I. Kushner, and H. Baumann, eds. CRC Press, Boca Raton, FL, p. 3.
4. Baumann, H., G. P. Jahreis, and K. K. Morella. 1990. Interaction of cytokine- and glucocorticoid-response elements of acute phase plasma protein genes. J. Biol. Chem. 265:22275.
5. Baumann, H., and J. Gauldie. 1990. Regulation of the hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol. Biol. Med. 7:147.
6. Won, K., S. P. Campos, and H. Baumann. 1993. Experimental systems for studying hepatic acute phase response. In Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. A. Mackiewicz, I. Kushner, and H. Baumann. eds. CRC Press, Boca Raton. FL. p. 255.
7. Luster, M. I., D. R. Germolec, T. Yoshida, F. Kayama, and M. Thompson. 1994. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19:480.
8. Morrison, D. C., and L. F. Kline. 1977. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J. Immunol. 118:362.
9. Reid, R. R., A. P. Prodeus, W. Khan, T. Hsu, F. S. Rosen, and M. C. Carroll. 1997. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J. Immunol. 159:970.
10. Ember, J. A., M. A. Jagels, and T. E. Hugli. 1998. Characterisation of complement anaphylotoxins and their biological responses. In The Human Complement System in Health and Disease. J. E Volanakis and M. M. Frank, eds. Marcel Dekker, Inc., New York, p. 241.
11. Okusawa, S., K. B. Yancey, J. W. M. van der Meer, S. Endres, G. Lonnemann, K. Hefter, M. M. Frank, J. F. Burke, C. A. Dinarello, and J. A. Gelfand. 1988. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. J. Exp. Med. 168:443.
12. Okusawa, S., C. A. Dinarello, K. B. Yancey, S. Endres, T. J. Lawley, M. M. Frank, J. F. Burke, and J. A. Gelfand. 1987. C5a induction of human interleukin 1: synergistic effect with endotoxin or interferon-γ J. Immunol. 139: 2635.
13. Scholz, W., M. R. McClurg, G. J. Cardenas, M. Smith, D. J. Noonan, T. E. Hugli, and E. L. Morgan. 1990. C5a-mediated release of interleukin 6 by human monocytes. Clin. Immunol. Immunopath. 57:297.
14. Nataf, S., N. Davoust, R. S. Ames, and S. R. Barnum. 1999. Human T-cells express the C5a receptor and are chemoattracted to C5a. J. Immunol. 162:4018.
15. McCoy, R. L., D. L. Haviland, E. P. Molmenti, T. Ziambaras, R. A. Wetsel, and D. H. Perlmutter. 1995. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182:207.
16. Buchner, R. R., T. E. Hugli, J. A. Ember, and E. L. Morgan. 1995. Expression of functional receptors for human C5a anaphylotoxin (CD88) on the human hepatocellular carcinoma cell line HepG2: stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylotoxin. J. Immunol. 155:308.
17. Haviland, D. L., R. L. McCoy, W. T. Whitehead, H. Akama, E. P. Molmenti, A. Brown, J. C. Haviland, W. C. Parks, D. H. Perlmutter, and R. A. Wetsel. 1995. Cellular expression of the C5a anaphyloloxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154:1861.
18. Osmand, A. P., B. Friedenson, H. Gewurz, R. H. Painter, T. Hofmann, and E. Helton. 1977. Characterisation of C-reactive protein and the complement subcomponent CIt as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc. Natl. Acad. Sci. USA 74:739.
19. Pepys, M. B., M. L. Baltz, F. C. de Beer, R. F. Dyck, S. Holford, S. M. Breathnach, M. M. Black, C. R. Tribe, D. J. Evans, and A. Feinstein. 1982. Biology of serum amyloid P component. Ann. NY Acad. Sci. 389:286.
20. Agrawal, A., J. M. Kilpatrick, and J. E. Volanakis. 1993. Structure and function of human C-reactive protein. In Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. A. Mackiewicz, I. Kushner, and H. Baumann. eds. CRC Press, Boca Raton, FL, p. 79.
21. Bodmer, B., and R. Siboo. 1977. Isolation of mouse C-reactive protein from liver and serum. J. Immunol. 118:1086.
22. Whitehead, A. S., K. Zahedi, M. Rits, R. F. Mortensen, and J. M. Lelias. 1990. Mouse C-reactive protein: generation of complementary DNA clones, structural analysis, and induction of messenger RNA during inflammation. Biochem. J. 266:59.
23. Siboo, R., and E. Kulisek. 1978. A fluorescent immunoassay for the quantification of C-reactive protein. J. Immunol. Methods 23:59.
24. Le, P. T., M. T. Muller, and R. F. Mortensen. 1982. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine. J. Immunol. 129:665.
25. Zhang, D., S.-L. Jiang, D. Rzewnicki, D. Samols, and I. Kushner. 1995. The effects of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level. Biochem. J. 310:143.
26. Depraetere, S., J. Willems, and M. Joniau. 1991. Stimulation of CRP secretion in HepG2 cells: cooperative effect of dexamethasone and interleukin 6. Agents Actions 34:369.
27. Toniatti, C., R. Arcone, B. Majello, M. Ganter, G. Arpaia, and G. Ciliberto. 1990. Regulation of the human C-reactive protein gene: a major marker of inflammation and cancer. Mol Biol. Med. 7:199.
28. Ganter, U., R. Arcone, C. Toniatti, G. Morrone, and G. Ciliberto. 1989. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 8:3773.
29. Ganapathi, M. K., D. Rzewnicki, D. Samols, S.-L. Jiang, and I. Kushner. 1991. Effect of combinations of cytokines and hormones on synthesis of serum A amyloid and C-reactive protein in Hep 3B cells. J. Immunol. 147:1261.
30. Lin. B-F., N.-O. Ku, K. Zahedi, A. S. Whitehead, and R. F. Mortensen. 1990. IL-I and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP). Inflammation 14:297.
31. Szalai, A. J., F. W. van Ginkel, S. A. Dalrymple, R. Murray, J. R. McGhee, and J. E. Volanakis. 1998. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J. Immunol. 160:5294.
32. Horowitz, J., J. E. Volanakis, and R. E. Stroud. 1979. Rabbit CRP production after inulin injection. Proc. Soc. Exp. Biol. Med. 160:222.
33. Pepys, M. B., and S. L. Rogers. 1980. Complement-independence of the acute-phase production of serum amyloid P-component (SAP) in mice. Br. J. Exp. Path. 61:156.
34. Szalai, A. J., D. E. Briles, and J. E. Volanakis. 1996. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect. Immun. 64:4850.
35. Szalai, A. J., D. E. Briles, and J. E. Volanakis. 1995. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol. 155:2557.
36. Ciliberto, G., R. Arcone, E. F. Wagner, and U. Rüther 1987. Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J. 6:4017.
37. Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262.
38. Circolo, A., G. Gamier, W. Fukuda, X. Wang, T. Hidvegi, A. J. Szalai, D. E. Briles, J. E. Volanakis, R. A. Wetsel, and H. R. Colten. 1999. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extra-hepatic expression of C3 mRNA. Immunopharmacol. 42:135.
39. Wetsel, R. A., D. T. Fleischer, and D. L. Haviland. 1990. Deficiency of the murine fifth complement component (C5): a 2-base pair gene deletion in a 5′-exon. J Biol. Chem. 265:2435.
40. Nunomura, W., Y. Takakuwa, and T. Higashi. 1994. Changes in serum concentration and mRNA level of rat C-reactive protein. Biochim. Biophys. Acta 1227:74.
41. Zabern, I. V., B. Hinsch, H. Przyklenk, G. Schmidt, and W. Vogt. 1980. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage. Immunobiology 157:499.
42. Van den Berg, C., P. C. Aerts, and H. Van Dijk. 1991. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J. Immunol. Methods 136:287.
43. Lim, H. W., D. He, S. Esquenazi-Behar, K. B. Yancey, and N. A. Soter. 1991. C5a, cutaneous mast cells, and inflammation: in vitro and in vivo studies in a murine model. J. Invest. Dermatol. 97:305.
44. Osaka, H., A. McGinty, U. E. Höepken, B. Lu, C. Gerard, and G. M. Pasinelti. 1999. Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience 88:1073.
45. Zwirner, J., T. Werfel, H.-C. Wilken, E. Thiele, and O. Götze. 1998. Anaphylotoxin C3a but not C3a (desArg) is a chemotaxin for the mouse macrophage cell line 1774, Ear. J. Immunol. 28:1570.
46. Kilpatrick, J. M., J. F. Kearney, and J. E. Volanakis. 1982. Demonstration of calcium-induced conformational change(s) in C-reactive protein by using monoclonal antibodies. Mol. Immunol. 19:1159.
47. Volanakis, J. E., W. L. Clements, and R. E. Schrohenloher. 1978. C-reactive protein: purification by affinity chiomatography and physicochemical characterization. J. Immunol. Methods 23:285.
48. Taktak, Y. S., and B. Stenning. 1992. Solid phase enzyme immunoassays for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute-phase mouse sera. Horm. Metab. Res. 24:371.
49. Suffredini, A. F., G. Fantuzzi, R. Badolato, J. J. Oppenheim, and N. P. O'Grady. 1999. New insights into the biology of the acute phase response. J. Clin. Immunol. 19:203.
50. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
51. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: impact on the adaptive immune response, Curr. Opin. Immunol. 9:4.
52. Suffredini, A. F., and N. P. O'Grady. 1999. Pathophysiologic responses to endotoxin in humans. In Endotoxin in Health and Disease. H. Braude, D. C. Morrison, S. M. Opal, and S. N. Vogel, eds. Marcel Dekker, New York p. 830.
53. Kopf, M., H. Baumann, G. Freer, M. Freundenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Köhler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
54. Zheng, H., D. Fletcher, W. Kozak, M. Jiang, K. H. Hofmann, C. A. Conn, D. Soszynski, C. Grabiec, M. E. Trumbauer, A. Shaw, et al. 1995. Resistance to fever induction and impaired acute-phase response in interleukin-1 β-deficient mice. Immunity 3:9.
55. Leon, L. R., W. Kozak, J. Peschon, and M. J. Kluger. 1997. Exacerbated febrile response to LPS, but not turpentine, in TNF double receptor-knockout mice. Am. J. Physiol. 272:R563.